StockVS

NYSE · Specialty Chemicals · USD

Albemarle Corporation (ALB) Stock Analysis

Albemarle Corporation (ALB) is a Specialty Chemicals stock listed on NYSE and quoted in US Dollar.

Last Updated: October 21, 2026

ALB

$94.47

−$1.30 (−1.36%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare ALB with… →

ALB Key Statistics

As of Oct 21, 2026
Trading
Open
$95.50
Previous Close
$95.77
Day's Range
92.68–96.51
52-Week Range
88.01–221.00
Volume
2.80M
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
1.36
Valuation
Market Cap
$11.15B
P/E Ratio
349.89
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
8.75
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
0.79
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
1.89
EPS (ttm)Profit attributable to each share over the last twelve months.
0.27
Financials (FY)
Revenue (FY)
$5.14B−4.37%
Net Income (FY)
−$510.63M
Profit marginThe share of revenue left as profit after all costs and taxes.
3.80%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
118.01M
1-Year Return
+4.61%
Dividend and dates
Dividend
$1.64+1.71%
Ex-Dividend Date
September 11, 2026
Earnings Date
November 4, 2026
Avg Volume
2.37M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, ALB closed at $94.47, +4.61% over 1 year.

Albemarle Corporation (ALB) has a market capitalization of $11.15B.

In fiscal 2025, ALB reported revenue of $5.14B.

ALB Stock Return by Calendar Year

Albemarle Corporation (ALB) 10-year return: what $10,000 became

1 year
$10,000 $10,461
+4.61%
5 years
$10,000 $4,289
−57.11%
10 years
$10,000 $13,128
+31.28%

If you had invested $10,000 in Albemarle Corporation (ALB) 10 years ago, at the close on October 21, 2016, it would have been worth $13,128 at the close on October 21, 2026: +31.28% in total, +2.76% a year, with dividends reinvested. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−32.65%
2025+67.72%
2024−39.50%
2023−32.80%
2022−6.63%
2021+59.76%
2020+105.39%
2019−3.28%
2018−38.89%
2017+50.22%
2016 (partial year)+5.17%

As of October 21, 2026.

ALB Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$5.14B−$510.63M−9.9%
2024$5.38B−$1.18B−21.9%
2023$9.62B$1.57B16.4%
2022$7.32B$2.69B36.7%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$5.14B$668.72M$67.29M−$510.63M−9.9%
2024$5.38B$62.54M−$642.23M−$1.18B−21.9%
2023$9.62B$1.19B$190.18M$1.57B16.4%
2022$7.32B$3.07B$2.48B$2.69B36.7%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

ALB Dividend History

$1.62+0.6% vs 2024

Dividends per share, 2025 · 4 payments

YearDividends per sharePaymentsChange
2026*$1.223—
2025$1.624+0.6%
2024$1.614+0.6%
2023$1.604+1.3%
YearDividends per sharePaymentsChange
2026 (partial year)$1.223—
2025$1.624+0.6%
2024$1.614+0.6%
2023$1.604+1.3%
2022$1.584+1.3%
2021$1.564+1.3%
2020$1.544+4.6%
2019$1.474+9.9%
2018$1.344+4.7%
2017$1.284+319.7%
2016$0.311—

Most recent payment: $0.41 per share, ex-dividend September 11, 2026. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.

ALB Valuation vs Specialty Chemicals Median

Median of 70 stocks
MetricALBSpecialty Chemicals medianvs median
P/E349.8928.2912.4x the median
P/S ratio1.891.5918% above
Profit margin3.80%2.70%1.1 pts above

Medians across 70 Specialty Chemicals stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

All 20 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Albemarle Corporation (ALB) is capitalised at $11.15B on the latest close. The company sits in the Basic Materials sector, in the Specialty Chemicals industry. Headcount on file is 7,800.

ALB last closed at $94.47 on October 21, 2026. That is −$1.30 (−1.36%) against the previous close. Over the past 52 weeks the price has ranged from $88.01 to $221.00. The latest close sits 7.34% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $5.14B. That is −4.37% against the prior fiscal year, when revenue was $5.38B. The same year closed with a net loss of $510.63M. The reported profit margin is 3.8%. That is 1.1 percentage points above the Specialty Chemicals median of 2.7%. Trailing earnings per share are 0.27.

Across the 4 fiscal years on file, revenue moves from $7.32B in 2022 to $5.14B in 2025. Of those 4 years, 2 report positive net income.

Valuation Assessment

The trailing P/E ratio stands at 349.89. That is 12.4 times the Specialty Chemicals median of 28.29. On forward earnings the ratio is 8.75. The PEG ratio, which sets the P/E against expected earnings growth, reads 0.79. Measured against sales, the shares trade at 1.89 times revenue. On price-to-sales that is 18.39% above the Specialty Chemicals median of 1.59. The medians here are taken across 70 Specialty Chemicals companies that report the metric.

Beta against the wider market is reported at 1.36. Daily returns over the trailing 10 years annualize to a volatility of 48.7%. The trailing one-year total return is +4.61%. Across 10 years the annualized return works out at +2.76%.

Growth & Income

The trailing dividend yield is 1.71%. That is 0.1 percentage points below the Specialty Chemicals median yield of 1.78%. At the indicated rate that is $1.64 a share a year. The ex-dividend date on file is September 11, 2026. Dividends are recorded for 11 calendar years; 2026 shows 3 payments totalling $1.22 a share. The year before, 2025, totalled $1.62 a share.

Across the complete calendar years on file, 2020 returned +105.39% and 2024 returned −39.50%. Of the 9 complete calendar years on file, 4 finished higher. 2026 is still running; the total return is −32.65% year to date.

Peer Comparison

Albemarle Corporation (ALB) operates in the Specialty Chemicals industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Albemarle Corporation ALB $11.15B 349.9
Linde plc LIN $230.75B 32.3
The Sherwin-Williams Company SHW $81.88B 31.1
Ecolab Inc. ECL $80.76B 38.7

The Specialty Chemicals industry average P/E ratio is 28.3x. Albemarle Corporation trades at a P/E of 349.9.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Specialty Chemicals Stocks

View all Specialty Chemicals stocks →

Popular Basic Materials Stocks

View all Basic Materials stocks →

About Albemarle Corporation

Albemarle Corporation provides energy storage solutions worldwide. It operates through three segments: Energy Storage, Specialties, and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride for use in lithium batteries used in consumer electronics and electric vehicles; power grids and solar panels; high-performance greases; and specialty glass used in consumer appliances and electronics. The Specialties segment provides bromine and highly specialized lithium solutions for various industries, such as energy, mobility, connectivity, and health comprising fire safety compounds; bromine-based specialty chemical products, including elemental bromine, alkyl bromides, inorganic bromides, brominated powdered activated carbon, and various bromine fine chemicals; lithium specialties, such as butyllithium and lithium aluminum hydride; cesium products for the chemical and pharmaceutical industries; and zirconium, barium, and titanium products for pyrotechnical applications, including airbag initiators. This segment also provides organic synthesis processes in the areas of steroid chemistry and vitamins, and various life science applications, as well as intermediates for the pharmaceutical industry; technical services, including handling and use of reactive lithium products; and recycling services for lithium-containing by-products. The Ketjen segment offers clean fuels technologies, including hydroprocessing catalysts together with isomerization and alkylation catalysts; fluidized catalytic cracking catalysts and additives; and performance catalyst solutions comprising organometallics and curatives. It serves the grid storage, automotive, aerospace, conventional energy, electronics, construction, agriculture and food, pharmaceuticals, and medical device industries. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.

Visit website →